Search

The emergence of drug resistance among Human Immunodeficiency Virus (HIV) patients poses a significant challenge to the success of antiretroviral therapy (ART) programs globally. In Malawi, where HIV prevalence remains a major public health concern, the incorporation of Dolutegravir (DTG) into...